Re-use plan for asbestos-contaminated drugs likely to hit snag

Published: 2009-10-12 06:59:00

Updated: 2009-10-12 06:59:00

Several pharmaceutical companies, including Ilyang Pharm, will hit snag with a plan to recover active ingredients from about 1,000 medicines that are confirmed to have used talc or talcum powders with asbestos, as they are required to meet the local drug master file (DMF) regulations within the e...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK